Overview

Two-week Course Versus Conventionally Fractionated Chemoradiotherapy in Rectal Cancer

Status:
Unknown status
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
The investigators compare two-week course of chemoradiation (33 Gy in 10 fractions with oral capecitabine) and conventional chemoradiation (50.4 Gy in 28 fractions with 5-FU and leucovorin) in this randomized trial.
Phase:
Phase 3
Details
Lead Sponsor:
Jong Hoon Lee
Seoul St. Mary's Hospital
Treatments:
Capecitabine